Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Fish and Richardson
Daiichi Sankyo
Chinese Patent Office
Express Scripts

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040159

« Back to Dashboard
NDA 040159 describes MEDROXYPROGESTERONE ACETATE, which is a drug marketed by Sandoz Inc, Duramed Pharms Barr, Teva Pharms Usa, Barr, and Usl Pharma, and is included in six NDAs. It is available from seventeen suppliers. Additional details are available on the MEDROXYPROGESTERONE ACETATE profile page.

The generic ingredient in MEDROXYPROGESTERONE ACETATE is medroxyprogesterone acetate. There are nineteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.

Summary for 040159

Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Pharmacology for NDA: 040159

Ingredient-typeProgesterone Congeners

Suppliers and Packaging for NDA: 040159

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
medroxyprogesterone acetate
TABLET;ORAL 040159 ANDA Barr Laboratories Inc. 0555-0779 0555-0779-02 100 TABLET in 1 BOTTLE (0555-0779-02)
medroxyprogesterone acetate
TABLET;ORAL 040159 ANDA Barr Laboratories Inc. 0555-0779 0555-0779-04 500 TABLET in 1 BOTTLE (0555-0779-04)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Aug 9, 1996TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Aug 9, 1996TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Aug 9, 1996TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Federal Trade Commission
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus